N
Google TrendPANTHERS VS BLUE JACKETS (200+) — Gameday 7: Florida Panthers at Columbus Blue Jackets
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:panthers vs blue jackets200+posiciones de atlético de madrid contra manchester united5000+devils vs red wings2000+lioness season 35000+tresoldi200+street fighter movie early reviews2000+luis díaz200+halle berry child custody hearing200+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Axicabtagene ciloleucel a" (30 stories)

Top Headline Story

Axicabtagene ciloleucel in combination with rituximab for refractory large B cell lymphoma: the phase 2, single-arm ZUMA-14 trial
Lead StoryNaturegeneral
Jan 5

Axicabtagene ciloleucel in combination with rituximab for refractory large B cell lymphoma: the phase 2, single-arm ZUMA-14 trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFAxOVZ3UFVlYmlKdGNhVTk3dzRSS0wtMlF3aTl5c0NnUTkzRGhPMjc3SUJnbXJ3T1k1RXpkYy1fSWVQNVdtdWZsWm1uOGdPZjk0d2I1Q3BXUzZYZFFHTjI4?oc=5" target="_blank">Axicabtagene ciloleucel in combination with rituximab for refractory large B cell lymphoma: the phase 2, single-arm ZUMA-14 trial</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
200+16m ago

panthers vs blue jackets

Gameday 7: Florida Panthers at Columbus Blue Jackets

Filter stories
5000+26m ago

posiciones de atlético de madrid contra manchester united

Atlético 2 - 0 Manchester United: resumen, goles y resultado de la Champions League

Filter stories
2000+26m ago

devils vs red wings

Devils at Red Wings projected lineups

Filter stories
5000+26m ago

lioness season 3

Thank Zoe Saldaña for ‘Lioness’ Season 3’s Perfect Cliff-Hanger

Filter stories

Search Results for "Axicabtagene ciloleucel a"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Axicabtagene Ciloleucel in Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-up of ZUMA-5
The ASCO Postgeneral

Axicabtagene Ciloleucel in Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-up of ZUMA-5

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxNQS1lZGZLc0pra1E3VTdFLWQwd2pHZGNtVXpadTV5c0QxN3VTSUtZTEVoZVBCTnNXZk11YkhjWTU2RmdXTDR4a0cwdWx0WXU2NUs1aldjd09sd2dlenhxMGlaeHU1OFZ0T240cFhoX1ZSdlAzNGJPZDg1dDRpdjJuTnRPRHJ1RVN3QUhCdVYtbmYwUnRDbjdFSFA4dmRVNmtPbWZlR3dOWUNXcVdfdFYxZWgxWGxBVEVPZEFMeA?oc=5" target="_blank">Axicabtagene Ciloleucel in Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-up of ZUMA-5</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
NEJMgeneral

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE5PaS1VaEhISy1nZHpkVEk2VzJMUE83akFkUzRReWg3TENvRDJIS3hNMVpVZWdoQ2g4UHVoUDhIck9NQlJvODdXUXBZLUE5UGVJNjBSa3kxcVB4dzFGaVZUOA?oc=5" target="_blank">Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma</a>  <font color="#6f6f6f">NEJM</font>

Read Full StoryMore like this
ZUMA‐7 trial shows the value of axicabtagene ciloleucel for early relapsed B‐cell lymphoma
Wiley & Sonsgeneral

ZUMA‐7 trial shows the value of axicabtagene ciloleucel for early relapsed B‐cell lymphoma

<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE9jLUJYeUNSVnZSUUJNZVFHRXlfR0ctM1hYb01zY2VSbUp1ZmVIWW9rVTRxSnhNanVUNHluc0ZNYzJPYzhjWmliQ29qRnp4ZW9TemJkemQxZ2N2aUdqQ1RlNmI2SWJDWEZwSkFiYlEzMHhOZ0NQ?oc=5" target="_blank">ZUMA‐7 trial shows the value of axicabtagene ciloleucel for early relapsed B‐cell lymphoma</a>  <font color="#6f6f6f">Wiley & Sons</font>

Read Full StoryMore like this
Axicabtagene Ciloleucel Shows Encouraging Efficacy and Safety in Central Nervous System Lymphoma
ASCO Daily Newsgeneral

Axicabtagene Ciloleucel Shows Encouraging Efficacy and Safety in Central Nervous System Lymphoma

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxPQUpZd3VGNW1QSTViSXdoVXNwb2NhSFA5dTRzUU5PN0htRVMtanlCUm42NFRiQVdzWHZPLWJsdGl3aHNpbHpSWG9nR1pEVlE3eVdEamVpSTNlUVBvWWZ2MVI0YjlNZU53dzcwaFozQzdsaUoxSDQwQ0I2bFp1SEpfTWVobUhJNkJ5RkFxc0J6YzZ5c0J6OXhtbHBobjV5QjVQUV9kQThES0N3Qmlfa1ZyTm9peDdndDVHNHc?oc=5" target="_blank">Axicabtagene Ciloleucel Shows Encouraging Efficacy and Safety in Central Nervous System Lymphoma</a>  <font color="#6f6f6f">ASCO Daily News</font>

Read Full StoryMore like this
CAR T-Cell Therapy with Axicabtagene Ciloleucel
Cleveland Clinicgeneral

CAR T-Cell Therapy with Axicabtagene Ciloleucel

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxQNzNGRkd5ZHNQVFRqSmFDbEFoZF9zMHhNcWdHZ1lDUjdOZ2oxbHlsNFhQUGE1VzdJU25lQ3BteUcxZkFGR1JXLXBKYWFrbUVIclFScFNfakhLTXROVDhwbnpRakx6bXZ4ZWE4SXQ2Z0Q4NmJZRkJZNFhHZHo5dmlGRkxFMmtSMDFVZGN0RU9n?oc=5" target="_blank">CAR T-Cell Therapy with Axicabtagene Ciloleucel</a>  <font color="#6f6f6f">Cleveland Clinic</font>

Read Full StoryMore like this
FDA Approval Sought for Axicabtagene Ciloleucel in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
OncLivegeneral

FDA Approval Sought for Axicabtagene Ciloleucel in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxNUXVjWG9PRFA4amRTb3NPdmRhN25Kb05TR2ZXQlpDRldrT1M1SzBQRzQxR1ZVa0dRb1VfaXpwbXpJQkVseXEzYVZzakdWTVZMSWVla214S1E3Z2hTSmY4LTMtM0lBNWVNYVd3c0E3dnpaMTROUVJLS0JqbklONHJaRkVqZVIwaGxMQ0pDdFJpODdfQmFBXzM0MXRHaTFJTjBsQzl6N1dNT3NtRnd1VEVLbzdKMnRxWTJGRFBwag?oc=5" target="_blank">FDA Approval Sought for Axicabtagene Ciloleucel in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
Real-World Comparison of Axicabtagene Ciloleucel and Lisocabtagene Maraleucel in Large B-Cell Lymphoma
CancerNetworkworld

Real-World Comparison of Axicabtagene Ciloleucel and Lisocabtagene Maraleucel in Large B-Cell Lymphoma

<a href="https://news.google.com/rss/articles/CBMi0wFBVV95cUxPMW1Bak5HS1JXblZyVDJkQTdfZFR1eGFrQ0pnSENpTkNjazlCQnNyeDZUcXB6MGxQM2FsRnNrTlllN3hFLUdwc2ZXOHNXSkZlYkVDVmVVYTJfU0FuT2FtYzV1T0lKRUpKZkEwNVd3SnFYcHZxWV9JdTB0OHNVelFWUnZFWWhmOXJUZW5VbDVweXBpWHBsLW9jeG04M25Kc3NhZ0VtQm9XbDZiaUw0LV9mcTl2YTNGQ0xvckowQ3dKMG9yRDNZV0dwQklKdzlOQ3hGdWhr?oc=5" target="_blank">Real-World Comparison of Axicabtagene Ciloleucel and Lisocabtagene Maraleucel in Large B-Cell Lymphoma</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryMore like this
Feasibility of axicabtagene ciloleucel in the outpatient setting: primary analysis of prospective trial
Naturegeneral

Feasibility of axicabtagene ciloleucel in the outpatient setting: primary analysis of prospective trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBIdDFhbXZiOExZUjFvS0NfemNrM1JBQW03WV9oRFFUdUZGRFN4T2thdENLWkdralZxejdlMFI5eXBORng2N3Z6a3lzV2N5dlVJVmtEeVotMV9kMm5EUkpz?oc=5" target="_blank">Feasibility of axicabtagene ciloleucel in the outpatient setting: primary analysis of prospective trial</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma
NEJMgeneral

Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE5hcXV2NldXeGtsUjJxdnVrZ3hGRHpRRW9XMzV0LTk1YVhaQWxJdmkxbW5Pa1FhZ21QVE9LSmdraGtoN2pIVm1mclZZbFR1akRUUTNlZENLbERKYjlMMDVvcA?oc=5" target="_blank">Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma</a>  <font color="#6f6f6f">NEJM</font>

Read Full StoryMore like this
FDA Grants Accelerated Approval to Axicabtagene Ciloleucel for Relapsed or Refractory Follicular Lymphoma
The ASCO Postgeneral

FDA Grants Accelerated Approval to Axicabtagene Ciloleucel for Relapsed or Refractory Follicular Lymphoma

<a href="https://news.google.com/rss/articles/CBMi4gFBVV95cUxQZWZRV1hHMDFwVTQyLUFUVDA4a0RYODdNMmJWTVc1SUxzUHJpV1g5c0dMVDJIZjNqTFR4dTRaQ2Z2V1NuTTYxVGhuZldnOEtZZEVnQUcwc0JfUEsyZGVpU1B6bWI1TmYzNnZ4RU1OYWkxeUtVUGQ3eVhTSmxWeTZtaWlXQmNac1NSLTNfTVZpR2puYTZNUldraXRabWJLM2JrVlA2UmZ2YlUyUVNLVENZbnFGbUY4OVdhcUwzR3ZYZV9EZWlfRy1wOXVFSFdiLWJwdkJjMEdTLXRTQVdqcmNrRWxB?oc=5" target="_blank">FDA Grants Accelerated Approval to Axicabtagene Ciloleucel for Relapsed or Refractory Follicular Lymphoma</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial
Naturegeneral

Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9kaVhaU2o2ZGxicy1Kal9KWFEtSVotUEFfOGdZQ3pUR0w5V1BUUmRUd2pUck9fUnd2YmFEZ3dKYzh5d3R5T1ZpaGZKRkF2YkVlaFkydzZSV3FSRE1jdnhv?oc=5" target="_blank">Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
NEJMgeneral

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE15VkhRQ1lPZFpRYVJwUGNITTF4MVU4SXQ3cjZRRlk2XzNOR0RGWUlfN0RDSTJkWHkzLXdjMUdHYUFKajQ0cXA5d3VyTU9TMVJZLVRXMVVoQ1hsMkV5TzZqeg?oc=5" target="_blank">Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma</a>  <font color="#6f6f6f">NEJM</font>

Read Full StoryMore like this
FDA Approves Axicabtagene Ciloleucel for the Second-Line Treatment of Large B-Cell Lymphoma
The ASCO Postgeneral

FDA Approves Axicabtagene Ciloleucel for the Second-Line Treatment of Large B-Cell Lymphoma

<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxORFdVUVQ0NTdEWnFjWUJPcTFLa2lDeFFUdHplOHBwQl93YzdlOWZkdzlmMENCak1JZW9jSDU5d2J2akJiT3FEQmgyVU5MQjl3RHVpOVJiQWJLcjZDWTZFT3ZCTElraXZzYkNfRkRsYmFWWTdZYzJ3ckZ4R29VRDhCal9SdDZGa0JDRW9XQlJMYmp1SUNtSF9QZHJueFlUVGJ3UDUyaHUyS3ByM09MaDkyY2xVeHJoQW41Ql9PYnVvWUdLdFVrUFpCRkx6emdqS00?oc=5" target="_blank">FDA Approves Axicabtagene Ciloleucel for the Second-Line Treatment of Large B-Cell Lymphoma</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial
Naturegeneral

Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBkUUZDSW5acnREUnZGWmpYYXdqY3JWTmRqNmRLZEtZbmJGOEU1LUhWbjhqQlI2c050Y2FadFo5a3FaS0hja1Vudm9sRENIa1IxVUZaMGJPS1E2VlRwTFpF?oc=5" target="_blank">Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Axicabtagene Ciloleucel in Refractory Large B-Cell Lymphoma 5-Year Results of the ZUMA-1 Trial
The ASCO Postgeneral

Axicabtagene Ciloleucel in Refractory Large B-Cell Lymphoma 5-Year Results of the ZUMA-1 Trial

<a href="https://news.google.com/rss/articles/CBMi0wFBVV95cUxNT2xPUnBkem03Qjg2MEtiSk5Xbi0zLWxJb05uZG5PdW5LOV9FbExfYUtNd1E3ekpDREc2bmNjaWRIbU51M3JyM3RxaFktR2RMdGprUW9lUlpSc2R1QnNKa0pGSmZway1NdURQUzFDNjJ4Z1hMRmdHdHRDVHNPTi1wVGVmVUVvY0hFY2NCZ0RJbUtOcEM2R0ZLVWNUNlhCaHpkWDM0eUwwZ182MHBxMlpIYVg2dFg2SzAycXl0eHV1aC1Xc0ZVUmMwazFKVTV1LWQza29z?oc=5" target="_blank">Axicabtagene Ciloleucel in Refractory Large B-Cell Lymphoma 5-Year Results of the ZUMA-1 Trial</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma
Natureworld

A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1ad05SOU1sQ1oyZzZJanYwLUtLOFFGUVVEZUFsU0ZvVWVBX2xlalVIYnBfRGJWcy1FQlVaNFZpcllZWEtpVFRVVzlabzFMQnVWZ3Rxa1RqVV92ZHlIVmU0?oc=5" target="_blank">A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Overall Survival With Axicabtagene Ciloleucel in Large B-Cell Lymphoma Results From ZUMA-7
The ASCO Postgeneral

Overall Survival With Axicabtagene Ciloleucel in Large B-Cell Lymphoma Results From ZUMA-7

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxNV1J0dUtsNnRFSzZDU0ZiUGJuSDlCQ2VoSmxybENmdVQ0aWFNZmtDd1RIWDZYVTllVnNtcGJrMzZiTU43X3B3d0RPUHMxM3FZalkyRVNfTnZfRzR6REx2NW1pQmdVbzU5Q3NsUlZpM3QwMmJPRlNqWFRMazQ4YVFLRDkwckFYTXFEejQwaG1iM0ZiQUZ6ZTJ5dG9KMjhmZEIyYXZkT1VvcEhDb245aUl4dkM2UzB1cXE1WWNldFp6RGtuTjZjVlE?oc=5" target="_blank">Overall Survival With Axicabtagene Ciloleucel in Large B-Cell Lymphoma Results From ZUMA-7</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids | Bone Marrow Transplantation
Naturegeneral

Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids | Bone Marrow Transplantation

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9qb19GSkhfbmJSM2RLeWMxU1F4elc0UmZ5cDlCd21zTTRtbjRmaFUyWHVTM3poeGFRN29iQlQyY1k1Y21DdDFxdEo4NFlkcW41YjRhSUFndThMWHY4QUMw?oc=5" target="_blank">Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids | Bone Marrow Transplantation</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
ZUMA-23: A Global, Phase 3, Randomized Controlled Study of Axicabtagene Ciloleucel Versus Standard-of-Care as First-Line Therapy in Patients With High-Risk Large B-Cell Lymphoma
OncLivegeneral

ZUMA-23: A Global, Phase 3, Randomized Controlled Study of Axicabtagene Ciloleucel Versus Standard-of-Care as First-Line Therapy in Patients With High-Risk Large B-Cell Lymphoma

<a href="https://news.google.com/rss/articles/CBMiqwJBVV95cUxOTlY4YmY4WEJ6OE5sTUwyLWVBVWIzb3ZFdW5maTdUOGhFQzRIWnlGektQNk5BdXMwX280WVlmSTFjczl6ZVdXVUVCcVZ2TDhvb0Z4cExuMzVpQW96Zm85U2FnSjdfR3VjOU1KMW1FUVVYckZaOVpyWTdNWTBYaWozUmhIUWpvSm5BZm9CZUtIRVNCX3ZGelBKLW94OXlub2o4aWIzdEJCTFF5cmdBRi1pT3lvcnJGNDVKVnBtVnJXdEx2cHNPajBmNHpSaEw2S1ZvTlBRS1Nwa2stQWVseHNEYTc5cGFkNEhTYTc2aGRNdncxQW1DMS00V01tTEZyTVpYN1RLUl9zRjVHQkpJSTIwczlYbnRyV2hzSzEwZk5HQWNHWm45bnRYUExzZw?oc=5" target="_blank">ZUMA-23: A Global, Phase 3, Randomized Controlled Study of Axicabtagene Ciloleucel Versus Standard-of-Care as First-Line Therapy in Patients With High-Risk Large B-Cell Lymphoma</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
FDA Approves New Label Update for CAR T-Cell Therapy Axicabtagene Ciloleucel
The ASCO Postgeneral

FDA Approves New Label Update for CAR T-Cell Therapy Axicabtagene Ciloleucel

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxQTUllRkpIUlBYLXFLeEdvV0ZlNGpjRTBNZF82RG9rdWRZU2d3ZDNfYlByaTNGakJiWGhoejk2MU9jSE5IcHdTUnBiSm55cTRkUFB6TDRmZkZvU1dGbHBLZm4xUF85Z1dhYURGWTVjempCeGJVdmpZS2RTdjVuem0yeVpqTFV1NjJkc3ZFV3Z3d3RpTnBRNV9KZnplZWRvWjBPczdicWRKd25rajhYYi1ZNnB0bjBHeFVm?oc=5" target="_blank">FDA Approves New Label Update for CAR T-Cell Therapy Axicabtagene Ciloleucel</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
Axicabtagene Ciloleucel for Large B-Cell Lymphoma
The ASCO Postgeneral

Axicabtagene Ciloleucel for Large B-Cell Lymphoma

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxQRGc1ZWlIMUpJcjdZV1cxbWhxN2VXdVhHSXoxTUFPMlJpNm9wbGI0bnhUaVVXRFpjeXJkbldNMWhXWEh4S0VjaFdQbUxCVjB0ak8yQUFOZmpWZXlfR2VOSVd2QkNDWTloSDJsRUE3QU5GYlFyMEQ4U3A3QU8xSWU2dElNWmtteEVpaThWSmZ0VTgtSHNkaFNqVkxZbw?oc=5" target="_blank">Axicabtagene Ciloleucel for Large B-Cell Lymphoma</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
Yescarta (axicabtagene ciloleucel) for the Treatment of Large B-Cell Lymphoma
Clinical Trials Arenageneral

Yescarta (axicabtagene ciloleucel) for the Treatment of Large B-Cell Lymphoma

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxPWTdGT0hpbHEyNkhoTHh3bWRwSnZUS1FhakU5ZnprSi04ZmdMVEJHLXhkRFlyVmYwUkpjVGVxZ3Z6RlU4UUw0QU56ZGs0OFQxU0ExYnV1NkJZRXM3OFNCbmFCVHdjTWdXckItWUYyN0VUMTNQM2YxWVg2NFFqenlJNVlXZXV6RHVSU1hlZkRIMUJBbUdzN1NkQml2cTYzUW1JSDIzT1dyZ0JscVlLNWww?oc=5" target="_blank">Yescarta (axicabtagene ciloleucel) for the Treatment of Large B-Cell Lymphoma</a>  <font color="#6f6f6f">Clinical Trials Arena</font>

Read Full StoryMore like this
FDA Approves Axicabtagene Ciloleucel for Second-Line LBCL
OncLivegeneral

FDA Approves Axicabtagene Ciloleucel for Second-Line LBCL

<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxNQ2V3cjk4c2xMekx4ZzJlcGI1M3R2NTVvX3hkN2NTemFkM1hrVUpyVURhcmhyby1JUFVsZ3Z3b25SVjIxMWo2ZEpDSUJoc1h3RGRFREx6UWxNUC1yQVNGUk03Y19IczhocTc5cTRjTDU2dk50TXR0cUliNXhmZ3pPZjRfc2RRVFZCVnhPUEY2TQ?oc=5" target="_blank">FDA Approves Axicabtagene Ciloleucel for Second-Line LBCL</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
Axicabtagene Ciloleucel CAR T-Cell Therapy Active in Refractory Large B-Cell Lymphoma
The ASCO Postgeneral

Axicabtagene Ciloleucel CAR T-Cell Therapy Active in Refractory Large B-Cell Lymphoma

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxPZHg5ZDRnRTU0TVpqV3ExVlZJQlQ2VE5wLVhSb1M2RDlKT1d1VmtKbkZOeWxWYzNmZ3lBazFpc0YzWHFtVXRhV1lBQTFYcnFIajNqMHhwdFZUQUczdnkyUzk5eW5FUDFkczRtOUdPYXJoMGR3c1lvUEdMVnN1UVUxX0lFTS1MVTd0ZWJ1RXZfdjZTRUlPU2MzV25WVk5CT2xtaFRscmF5Yw?oc=5" target="_blank">Axicabtagene Ciloleucel CAR T-Cell Therapy Active in Refractory Large B-Cell Lymphoma</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
Axicabtagene Ciloleucel Safe and Tolerable for Relapsed, Refractory Central Nervous System Lymphoma
Pharmacy Timesgeneral

Axicabtagene Ciloleucel Safe and Tolerable for Relapsed, Refractory Central Nervous System Lymphoma

<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxOQjZTUHlWV05jcDVYak5ORVItTHlDQUJaTmtyamVMRWhBc2hIUU5pcnVJbDJ0R0drS0ZyLXUwcDJfNXV5RW9ld21hOGotODBTd1FDa29sQmZFUDBBTHNlajQtMlI1S2I1WTh0ZFFJdDVkUmJuNV9JOTBJZE9HNXo3WGdjeEkxNnRudy04d0FWVW42Z0pUZGJPX2R1czFvc205VGVYQ3NkY1ljM0ZRTFpZYVdQXzBCa09jUlpyd0dDLTNCVHdKSGowMGZpTVM2QQ?oc=5" target="_blank">Axicabtagene Ciloleucel Safe and Tolerable for Relapsed, Refractory Central Nervous System Lymphoma</a>  <font color="#6f6f6f">Pharmacy Times</font>

Read Full StoryMore like this
Axicabtagene ciloleucel receives US FDA approval as second-line treatment for large B-cell lymphoma
Lymphoma Hubgeneral

Axicabtagene ciloleucel receives US FDA approval as second-line treatment for large B-cell lymphoma

<a href="https://news.google.com/rss/articles/CBMi2wFBVV95cUxPRXlBUFNLRURZcmpLM1IxYTF5bVdrUU5sMnAtcEliSVJDLVVwc1hrbzlKYVlxS2FpcEQ3ZGpfMkgwM0JvdGZackZXdWlZYzRlclBlajVoOTlKQWlCZ1plR25kbGxwQ2ZvcHVlU2M2eWlSak1NeFBIdmU3NXpOZXNLblE3Yk5YYmJzTzhpVmZKN2I2X1lsbGl5QUhaWXZFUEhDUHIyVWt1SV9SeWM3akVscGoweGxDd0dKVWF2QThZbm42UVBuU1Njc3NSbmpLbnBrSnctV0pBdjQ3NFE?oc=5" target="_blank">Axicabtagene ciloleucel receives US FDA approval as second-line treatment for large B-cell lymphoma</a>  <font color="#6f6f6f">Lymphoma Hub</font>

Read Full StoryMore like this
Rapid Readout: ZUMA‑7: Axicabtagene Ciloleucel versus Standard‑of‑Care Therapy in Patients with Relapsed/Refractory Large B‐Cell Lymphoma
OncLivegeneral

Rapid Readout: ZUMA‑7: Axicabtagene Ciloleucel versus Standard‑of‑Care Therapy in Patients with Relapsed/Refractory Large B‐Cell Lymphoma

<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxOQTBaZWRYYlJOZG5xWVY5T2JOYkhxWVdsWExTSFdHZjhLeGl6UVdqT0MxcUptNVJLSmI5d2hPVXpDVjVGX0xGRjdZVC1fcVJsSkE5WGZRT1JnSl9YX0xpa2JFaklUZ0NSSnpWOUMwb2ROQkRHaUVFR0I5YmpvMFBjX2NmSzdpT09Jb2JyNnJTYXU0U1AzajNrMG9fODBucTJ0VHhTOEhuZlYxU0JNTGlmQUlyWWU2dEN5LURnUVl0Nk1qNEliRTlSRUVvUUt4UkYzTkhUTEZFcHBiZkZHcmtWTHFtMzU?oc=5" target="_blank">Rapid Readout: ZUMA‑7: Axicabtagene Ciloleucel versus Standard‑of‑Care Therapy in Patients with Relapsed/Refractory Large B‐Cell Lymphoma</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
Axicabtagene ciloleucel approved for second-line treatment of large B-cell lymphoma
Medical Xpressgeneral

Axicabtagene ciloleucel approved for second-line treatment of large B-cell lymphoma

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxORnZoZkI5aGhZVHJLMFhOS1NNc2NOc3N0Ums5LTY2cEU0dzIydVBqM194cEY2bEJVVl85Y21yOG5SR2xzYlFielZuUzNRRlQ5YVozcF91VVBrRkxMOUNaRU40MnNmb3BrVHpjN3NySzBVTFRlVGRPdTN5QUs4VUxhUV9VUWY1OTNQdTJKVTIzd3AtaGt2Yk9xVmlaVQ?oc=5" target="_blank">Axicabtagene ciloleucel approved for second-line treatment of large B-cell lymphoma</a>  <font color="#6f6f6f">Medical Xpress</font>

Read Full StoryMore like this
Is CAR T-Cell Therapy Setting a New Standard of Care in Lymphoma?
The ASCO Postgeneral

Is CAR T-Cell Therapy Setting a New Standard of Care in Lymphoma?

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxPOXZ3LXdYSG8yX3BhM1g3Z2kwNTJUdjdXc3gwSkdTejFvTGhwa3FtMktEbVJJNnMyWjQ2alhzZ21aUW5iLXlUc3NSN09MR1pQSEl2aVlFR2dmeFBmT1oyeFM4MDhrR0pCV1VrRTJaYUp4MU9kNU5MMDBFQUFfLTVvLUZPY1A3RXJXX05RbFhucThRcDA?oc=5" target="_blank">Is CAR T-Cell Therapy Setting a New Standard of Care in Lymphoma?</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
"Axicabtagene ciloleucel a" — Live Google News Trends & Headlines